Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This compassionate use study is designed to monitor safety in patients who have been doing
well on pergolide therapy, wish to continue treatment, and have not been able to tolerate
alternative treatments.
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.